Novo Nordisk A/S (NVO) stock analysis

In our weekly check, Novo Nordisk A/S is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 7, red flags: 1.

About Novo Nordisk A/S

Novo Nordisk A/S is a Healthcare company (Drug Manufacturers - General) based in Denmark, listed on NYSE as NVO.

What our checks show for NVO

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-03

Similar companies

PFE · GILD · AMGN · BMY · AZN · SNY

Questions

What grade does Novo Nordisk A/S (NVO) have?

In our weekly check, Novo Nordisk A/S is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 7, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of NVO stock?

This week's biggest flags for Novo Nordisk A/S: Deep past fall, Gross margin falling, Weak EPS forecast. In total 8 of 25 checks show a warning or a red flag.

What does Novo Nordisk A/S do?

Novo Nordisk A/S is a Healthcare company (Drug Manufacturers - General) based in Denmark, listed on NYSE as NVO.

When does Novo Nordisk A/S report earnings next?

The next earnings report is expected on 2027-02-03. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis